Medical CBD has been a topic of passion for Steve Goldner, founder of Pure Green Pharmaceuticals, for several years. After originally co-inventing the liquid form of methadone to save lives from heroin overdoses, he was inspired by a friend who suffered from PTSD after the war. Goldner noticed that smoking cannabis helped his friend’s anxiety and psychological symptoms, however, at the time cannabis was illegal.
The promise of medical CBD is the future that Goldner saw and he set out advocating for the use of cannabis derivatives as medicine. On his journey, he was appointed as an FDA advisor to the US National Institutes of Health (NIH) to turn research into useful medical products and in that role he began encouraging others to look at cannabis in a new light.
CBD as a medicine was a stance Goldner encouraged the FDA and NIH to take, a step toward making cannabis legal as a regulated health product, and, while the system isn’t perfect, great strides have been made since the meeting five years ago.
Through careful research in a cannabis testing laboratory, he has created Pure CDB, a medical CBD in the form of a water soluble tablet. His goal is the same – to create medical CBD to help people with a range of chronic ailments.
The medical CBD developed by Pure Green Pharmaceutical improves lives by improving sleep, relieving pain, reducing anxiety, and more. A sister company, Pure Green LLC has the first license in Michigan as a cannabis pharmaceutical company and has already sold 700,000 of their medical CBD tablets since opening in mid-2018.
The CBD medicines in the Pure Green tablets were developed to be water soluble to improve bioavailability, resulting in more effective CBD medicinal delivery, saving patients on health care costs.
As the industry shifts and turns to medical CBD in the form of CBD oils or prescribed medical cannabis to treat symptoms, cannabis will enhance the future of pharmaceutical research, led by Goldner’s team at Pure Green.